Chimerix Still Fighting as SIGA Wins $2.8B Smallpox Contract
By Trista Morrison
Tuesday, May 17, 2011
Yet again, SIGA Technologies Inc. was awarded a potential $2.8 billion government contract for smallpox drug ST-246. And yet again, rival Chimerix Inc. is challenging the award.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.